|
Home : Unsafe Drugs : Avandia : Newsfeeds : Diabetes drugs go head-to-head in study Diabetes drugs go head-to-head in study
The new study, appearing in the Dec. 4 issue of BMJ , also found that the diabetes medications Actos (pioglitazone) and Avandia (rosiglitazone) did not seem to raise the risk of heart attack. But Actos was associated with a lower risk of dying than Avandia ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




